Navigation Links
Best Practices for Conducting Extractable and Leachable Studies, new life sciences webinar hosted by Xtalks
Date:5/8/2013

Toronto, Canada (PRWEB) May 08, 2013

Regulatory agencies expect that any container closure systems or components utilized in manufacturing the drug product do not adulterate the product. Appropriately designed extractables studies provide relevant and meaningful data, allowing for a detailed risk assessment.

Several different extraction solutions and analytical techniques may be employed to screen the components of interest for extractable compounds. Care must be taken in evaluating these methods to ensure that potential extractable compounds are capable of being observed.

Webinar attendees will walk away with a strong understanding of:

  •     Strategies for establishing an extractables study design
  •     Risk assessment based on product type
  •     Use of various analytical techniques and their benefits and drawbacks
  •     Tools utilized to handle difficult sample matrices
  •     Tools to handle Threshold of Toxicological Concern (TTC)
  •     Data sources useful for toxicological evaluation
  •     Tools to evaluate Tolerable Intake (TI) and Tolerable Exposure (TE)
  •     Design of studies to monitor leachable compounds

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit:
http://xtalks.com/extractable-leachable-eurofins-lancasterlabs.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10699504.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
2. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
3. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
4. BioInformatics LLC New Market Report – Best Practices Guide for Advertising to Life Scientists
5. How to Ensure Pharmacovigilance Practices are Compliant with Global Safety Requirements: Challenges in Asia-Pacific
6. First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
7. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
8. Reno Efficient Sustainable Practices Selected to Provide Water and Energy Conservation Services To the County of San Diego
9. Innovation Leaders from Across Industries will Convene to Share Best Practices and Breakthrough Successes at Open Innovation Leadership Summit
10. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
11. Challenges and Solutions in Conducting Biosimilar Trials, New Life Science Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... has validated a 0.2 ng/mL lower limit (LLOQ) assay for nicotine and two ... LLOQ assay, the ultra-low trace nicotine assay meets additional needs of tobacco industry ...
(Date:4/27/2017)... ... 2017 , ... Oncolinx, a spin-out of the Center for ... taken their cancer research out of this world. On April 22, 2017, an ... the International Space Station’s (ISS) U.S. National Laboratory, managed by the Center for ...
(Date:4/27/2017)... ... , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive ... a rare devastating genetic disease that leads to a sudden and rapid loss of ... patients carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms ...
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead ... ( http://www.paintherapeuticsummit.com ) is coming to San Diego, CA on September 27-28, 2017. ... learn about the latest advances in the treatment of various types of pain. ...
Breaking Biology Technology:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):